Amphastar Pharmaceuticals, Inc.
$1.32B- Market cap
- $986.88M
- Debt
- +$619.71M
- Cash
- −$282.81M
Capital structure 61% equity / 39% debt · EV / Revenue 1.84x · EV / EBITDA 6.20x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
AMPH · current priceP/E 11.43x
$23.20Latest market snapshot
Implied fair value · at AKR's multiple
$412.091,676.3% above market
2.03 AMPH EPS (TTM)×203.00x AKR P/E=$412.09
Market $23.20Implied $412.09
AKR · current priceP/E 203.00x
$20.30Latest market snapshot
Implied fair value · at AMPH's multiple
$1.1494.4% below market
0.10 AKR EPS (TTM)×11.43x AMPH P/E=$1.14
Market $20.30Implied $1.14